Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole for ovarian hyperstimulation syndrome after IVF
IRCT20141008019464N2Phase 2Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Sep 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of letrozole in ovarian hyperstimulation syndrome (OHSS) (2 arms), sponsored by Kerman University of Medical Sciences. Primary endpoint: Duration of ovarian hyperstimulation syndrome. Started Sep 2019; status: completed.
02
Drugs
letrozole
03
Conditions
ovarian hyperstimulation syndrome (OHSS)
Beyond the preview
Go deeper on IRCT20141008019464N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141008019464N2.